MedPath

Intervention Effect of TP and AOB-w on Acrylamide Exposure in Chinese Adolescents

Not Applicable
Completed
Conditions
Intervention
Interventions
Dietary Supplement: Tea polyphenols
Dietary Supplement: AOB-w
Other: Placebo
Other: Acrylamide (Potato Chips)
Registration Number
NCT03118167
Lead Sponsor
Zhejiang University
Brief Summary

A double-blind randomized controlled trial (RCT) was conducted in current human study. This study aims to investigate the intervention effect of AOB-w on the short-term exposure and toxicokinetics of acrylamide, a dietary hazardous substance generated during heat processing, in Chinese adolescents.

Detailed Description

In the morning of test day, participants were served with a meal of potato chips, corresponding to a single oral dose of 12.6 μg/kg b.w. exposure to acrylamide, and an edible capsule, which contains 350 mg AOB-w or the placebo with the same dose. Urine were collected within 48 hours thereafter. The diet was rigorously controlled within 24 hours prior to study till entire study finished. Four mercapturic acid metabolites have been investigated as urinary biomarkers for short-term internal exposure of acrylamide in human

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria
  • Subject has no smoking or drinking hobby
Exclusion Criteria
  • Having any drugs within 7days
  • Smoking or drinking
  • Pregnant, trying to become pregnant or breast feeding
  • Allergic frying foods

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo & AcrylamideAcrylamide (Potato Chips)Placebo (Starches) 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
AOB-w & AcrylamideAcrylamide (Potato Chips)AOB-w 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
Tea polyphenols & AcrylamideTea polyphenolsTP 0.05g, 0.1g, 0.2g (starches filled, up to 0.35g) capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
AOB-w & AcrylamideAOB-wAOB-w 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
Placebo & AcrylamidePlaceboPlacebo (Starches) 0.35g capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
Tea polyphenols & AcrylamideAcrylamide (Potato Chips)TP 0.05g, 0.1g, 0.2g (starches filled, up to 0.35g) capsule by mouth, Acrylamide (Potato Chips) 12.6μg/kg b.w. by mouth, for one single oral dose
Primary Outcome Measures
NameTimeMethod
Change of two hemoglobin adducts of acrylamidebaseline, 3 and 10 days

Blood samples were collected in 0, 3, 10days after the intake of potato chips meals. Two hemoglobin adducts (AAVal and GAVal) of acrylamide were detected by UHPLC-MS/MS.

Change of four urinary biomarkers of acrylamideup to 48 hours

Urine was collected prior to the potato chips meal and 48 hours thereafter, up to 10 urine samples for each participants. Urinary biomarkers of acrylamide were detected by UHPLC-MS/MS.

Secondary Outcome Measures
NameTimeMethod
Time to Peak Concentration (tmax) of Acrylamide Urinary Biomarkers48 hours

Time to Peak Concentration (tmax) of Acrylamide Urinary Biomarkers during the specified period, measured by curve fitting tools of Matlab Software.

Area under the concentration versus time curve (AUC) Of acrylamide urinary biomarkersbaseline, 2, 4, 6, 8, 10, 14, 24, 36 and 48 hours

Dynamic changes of biomarkers during the specified intervention period, following 10 urine samples in 48 hours thereafter.

Maximum Concentration (Cmax) of Acrylamide Urinary Biomarkers48 hours

Maximum concentration of urinary biomarkers during the specified period, measured by curve fitting tools of Matlab Software.

© Copyright 2025. All Rights Reserved by MedPath